- Home
- ALVR vs ORIS Comparison
ALVR vs ORIS Comparison
Compare ALVR & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVR
- ORIS
- Stock Information
- Founded
- ALVR 2013
- ORIS 2014
- Country
- ALVR United States
- ORIS China
- Employees
- ALVR N/A
- ORIS N/A
- Industry
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- ORIS Farming/Seeds/Milling
- Sector
- ALVR Health Care
- ORIS Consumer Staples
- Exchange
- ALVR Nasdaq
- ORIS Nasdaq
- Market Cap
- ALVR 46.6M
- ORIS 40.5M
- IPO Year
- ALVR 2020
- ORIS 2024
- Fundamental
- Price
- ALVR $9.38
- ORIS $1.52
- Analyst Decision
- ALVR
- ORIS
- Analyst Count
- ALVR 0
- ORIS 0
- Target Price
- ALVR N/A
- ORIS N/A
- AVG Volume (30 Days)
- ALVR 29.1K
- ORIS 2.2M
- Earning Date
- ALVR 03-14-2025
- ORIS 02-21-2025
- Dividend Yield
- ALVR N/A
- ORIS N/A
- EPS Growth
- ALVR N/A
- ORIS N/A
- EPS
- ALVR N/A
- ORIS 0.43
- Revenue
- ALVR N/A
- ORIS $16,745,999.00
- Revenue This Year
- ALVR N/A
- ORIS N/A
- Revenue Next Year
- ALVR N/A
- ORIS N/A
- P/E Ratio
- ALVR N/A
- ORIS $3.70
- Revenue Growth
- ALVR N/A
- ORIS N/A
- 52 Week Low
- ALVR $7.96
- ORIS $1.16
- 52 Week High
- ALVR $24.15
- ORIS $56.01
- Technical
- Relative Strength Index (RSI)
- ALVR 39.33
- ORIS N/A
- Support Level
- ALVR $7.96
- ORIS N/A
- Resistance Level
- ALVR $10.00
- ORIS N/A
- Average True Range (ATR)
- ALVR 1.14
- ORIS 0.00
- MACD
- ALVR 0.03
- ORIS 0.00
- Stochastic Oscillator
- ALVR 35.50
- ORIS 0.00
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is a company who is an integrated supplier of tea products in Mainland China. Their major tea products include primarily-processed tea consisting of white tea and black tea, and refined white tea and black tea. Its business operations are vertically integrated, covering cultivation, processing of tea leaves and the sale of tea products to tea business operators (such as wholesale distributors) and end-user retail customers in Mainland China.